ArticleEuropean journal of breast health2023

Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine.

İzzet Doğan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.